Questioning the Ban: E-cigarette Regulation in Argentina

Aug.15.2023
Questioning the Ban: E-cigarette Regulation in Argentina
Argentine e-cigarette association questions government regulations, claiming e-cigarettes reduce tobacco risks by 95%, calling for independent regulation.

According to Argentine media outlet Eleconomista, on August 14th, the Argentine e-cigarette association has raised concerns about the government's regulation policies on e-cigarettes. While acknowledging that e-cigarettes are not completely harmless, the association argues that for those who are unable or unwilling to quit smoking, e-cigarettes can reduce the risks associated with traditional tobacco by 95%. As a result, they are calling for independent regulation that does not treat e-cigarettes on par with traditional tobacco.


Approximately one million Argentines are currently using e-cigarettes.


E-cigarettes and heated tobacco products are gaining popularity worldwide, not only among those seeking non-combustible and lower nicotine options, but also among people who enjoy inhaling nicotine-free flavored vapor.


In Argentina, the use of these products has not been legally sanctioned, and it is estimated that there are currently around one million people nationwide using e-cigarettes.


However, since 2011, the sales, importation, distribution, promotion, and advertising of e-cigarettes have been prohibited according to the regulations set by the National Administration of Food, Drugs, and Medical Technology (ANMAT). Additionally, the Ministry of Health has banned the use of heated tobacco products starting from March 2023.


Compared to traditional cigarette smoking, the nicotine and approximately 7000 toxic substances in cigarettes are highly addictive and can potentially cause respiratory diseases, cardiovascular ailments, and various types of cancer, including lung, throat, and laryngeal cancers.


According to statistics released by the Ministry of Health in Argentina, 22.2% of adults over the age of 18 are smokers. Approximately 45,000 people die each year due to smoking, accounting for 14% of the total number of deaths.


Cigarette smoking continues to raise concerns every year due to its detrimental impact on health. Recent statistics reveal notable consequences, including 19,000 cancer diagnoses, 33,000 cases of pneumonia, 11,000 strokes, 61,000 hospitalizations caused by cardiovascular diseases, and over 100,000 new cases of chronic obstructive pulmonary disease (COPD).


Call for independent regulation.


An e-cigarette, formally known as a Nicotine Electronic Aerosolization System (SEAN) or a Non-Nicotine Electronic Aerosolization System (SESN), is a battery-operated device that heats a solution composed of propylene glycol, glycerin, and potentially flavorings to 250 degrees Celsius, producing an aerosol for consumer inhalation.


Furthermore, the heating of specially crafted tobacco leaves and pods containing nicotine in heated tobacco products (HTPs), without combustion, has been deemed toxic and carcinogenic by the World Health Organization (WHO). Therefore, the WHO states that HTPs should be regulated as "other products within the tobacco category" due to a lack of sufficient data indicating that they are less harmful than traditional cigarettes.


The Ministry of Health in Argentina has implemented strict regulations on e-cigarettes and PTC due to concerns about their potential health risks and addictive behavior.


However, the Argentine e-cigarette association acknowledges that e-cigarettes are not entirely harmless but claims that they reduce the risks associated with traditional tobacco by 95% for individuals who cannot or do not want to quit smoking.


As a result, they are calling for independent regulation and not treating it on par with traditional tobacco.


Juan Facundo Teme, chairman of the association, believes that the use of e-cigarettes in Argentina has been stigmatized. He is urging the government to study regulatory measures in countries like the United Kingdom and questions why prohibition is the only option for Latin American countries.


References: When writing articles or reports, it is crucial to include references to support the information provided. References serve as sources of evidence and credibility for the claims made in the piece. They allow readers to verify the information themselves and ensure accuracy. Citing references also demonstrates the author's research and diligence in gathering information from reliable sources. This adds depth and authority to the piece, increasing its reliability and trustworthiness. In academic writing, referencing is considered a standard practice, as it gives credit to the original authors and acknowledges their contributions to the field. It also helps to avoid plagiarism by clearly attributing ideas and information to their rightful owners. Proper referencing involves providing complete and accurate information about the sources used, including the author's name, publication date, title, and relevant details. Different citation styles, such as MLA, APA, and Chicago, have specific rules and formats for referencing various types of sources, such as books, journals, websites, and interviews. Including references in a written piece not only strengthens its credibility but also encourages further exploration and research on the subject matter. It allows readers to delve deeper into the topic and engage with the material on a more scholarly level. In conclusion, references play a vital role in journalistic writing. They elevate the quality and reliability of the piece, ensure accuracy, and recognize the contributions of others. By including proper references, writers demonstrate their commitment to intellectual honesty and integrity.


Vaping in Argentina: Is its prohibition reasonable?



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Managing Director Naeem Shahab Khan met Perlis Mufti Mohd Asri Zainul Abidin on September 17 and presented the company's shift from conventional cigarettes toward alternative products. The mufti said a product could be considered halal if it is clean, its side effects are not harmful or can be controlled, and it does not involve excessive waste. His remarks did not mention IQOS or any other specific PMI product and did not amount to a new product-specific religious ruling. It was at least the second publicly reported engagement between Philip Morris Malaysia and a Malaysian religious institution over cigarette alternatives within six months.
Regulations
Sep.18 by 2Firsts Perspectives
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
A 2Firsts analysis of Virginia's liquid nicotine and vapor product certification directory identified 213 product records from 15 manufacturers. Companies associated with BAT, Altria, Imperial Brands, JTI and JUUL account for 127 entries. The directory also includes independent brands CrossBar 20K, Loon and Breeze. CrossBar advertises a 13mL disposable capable of up to 20,000 puffs, while Loon has 16 disposable entries featuring fruit, cooling and beverage-related flavors. Of all records, 120 are labeled as under FDA PMTA review. Virginia introduced revised penalties on October 1, 2026, including a minimum first-violation civil penalty of $5,000 per unlisted product, alongside new retail tobacco permitting requirements.
Regulations
Oct.30
Ireland Raises Nicotine Product Taxes Again as Cigarettes Gain €1 and Vape Duty Is Set to Jump 40%
Ireland Raises Nicotine Product Taxes Again as Cigarettes Gain €1 and Vape Duty Is Set to Jump 40%
Ireland has increased tobacco excise under Budget 2027 and announced a further rise in its E-liquid Products Tax. From Oct. 7, the tax burden on a pack of 20 cigarettes in the most popular price category increased by €1, with pro-rata increases on other tobacco products. The government plans to raise EPT from €0.50 to €0.70 per millilitre from Jan. 1, 2027, a 40% increase applying to both nicotine-containing and nicotine-free e-liquids. The tobacco duty increase is expected to raise about €63.1 million in a full year.
Regulations
Oct.09
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands has agreed to acquire 100% of Swedish modern oral nicotine company Yoik Group AB for an initial SEK515 million, equivalent to about US$53.9 million, plus a deferred payment linked to performance over the next two years. Yoik owns nicotine pouch brand Helwit, which held about 3.4% of Sweden’s modern oral nicotine market over the past 12 months. Imperial says the acquisition will more than double its existing share of the Swedish market. Helwit is also sold elsewhere in the Nordics, through European online channels and in selected UK retail outlets.
Sep.08